AR-C-89855

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAR-C-89855
Drug Alias NameAR-C69457AAAR-C68475AAAR-C68164AAAR-C-89855AR-C89855AA
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-2 adrenergic receptor agonistsDopamine D2 receptor agonists
TargetsBeta-2 adrenergic receptorDopamine D2 receptor
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsPulmonary Disease, Chronic ObstructiveAsthma

Other Information

ATC CodeN/A
Related LinksN/A